Maxcyte (MXCT) Long-Term Investments (2023 - 2026)

Maxcyte (MXCT) has 4 years of Long-Term Investments data on file, last reported at $40.8 million in Q1 2026.

• Quarterly Long-Term Investments rose 12.05% year-over-year to $40.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.8 million (up 12.05% YoY) and the FY2025 annual result came in at $52.6 million, up 46.92% from the prior year.
• Long-Term Investments eased to $40.8 million in Q1 2026 per MXCT's latest filing, from $52.6 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $52.6 million in Q4 2025 and bottomed at $18.4 million in Q3 2023.
• The 4-year median for Long-Term Investments is $42.5 million (2024), against an average of $40.7 million.
• The widest annual swing landed in 2024, when Long-Term Investments jumped 132.23%; it then decreased 19.12% in 2025.
• Tracing MXCT's Long-Term Investments over 4 years: stood at $42.9 million in 2023, then declined by 16.67% to $35.8 million in 2024, then jumped by 46.92% to $52.6 million in 2025, then decreased by 22.37% to $40.8 million in 2026.
• Per Business Quant, the three latest MXCT Long-Term Investments figures stand at $40.8 million (Q1 2026), $52.6 million (Q4 2025), and $52.3 million (Q3 2025).

Peer Comparison